Sprouty2 (SPRY2) was downregulated in 31 HCC patients compared with their matched non-tumor tissues, indicating its critical tumor suppressor effects through the Ras/Raf/MEK/ERK signaling pathway [161]. The gene discussed is SPRY2; the disease is neoplasm.